233 related articles for article (PubMed ID: 18028219)
1. Quantitative in vitro demonstration of two-photon photodynamic therapy using photofrin and visudyne.
Khurana M; Collins HA; Karotki A; Anderson HL; Cramb DT; Wilson BC
Photochem Photobiol; 2007; 83(6):1441-8. PubMed ID: 18028219
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
Karotki A; Khurana M; Lepock JR; Wilson BC
Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
[TBL] [Abstract][Full Text] [Related]
3. Two-photon absorption cross section of excited phthalocyanines by a femtosecond Ti-sapphire laser.
Mir Y; van Lier JE; Allard JF; Morris D; Houde D
Photochem Photobiol Sci; 2009 Mar; 8(3):391-5. PubMed ID: 19255681
[TBL] [Abstract][Full Text] [Related]
4. One- and two-photon activated phototoxicity of conjugated porphyrin dimers with high two-photon absorption cross sections.
Dahlstedt E; Collins HA; Balaz M; Kuimova MK; Khurana M; Wilson BC; Phillips D; Anderson HL
Org Biomol Chem; 2009 Mar; 7(5):897-904. PubMed ID: 19225672
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J; Tsunoda Y; Ichinose S; Ishizumi T; Ohtani K; Maehara S; Ono S; Tsutsui H; Ohira T; Okunaka T; Furukawa K; Sugimoto Y; Kato H; Ikeda N
Lung Cancer; 2010 Feb; 67(2):198-204. PubMed ID: 19477032
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells.
Banfi S; Caruso E; Caprioli S; Mazzagatti L; Canti G; Ravizza R; Gariboldi M; Monti E
Bioorg Med Chem; 2004 Sep; 12(18):4853-60. PubMed ID: 15336264
[TBL] [Abstract][Full Text] [Related]
10. Carbon nanodots featuring efficient FRET for two-photon photodynamic cancer therapy with a low fs laser power density.
Wang J; Zhang Z; Zha S; Zhu Y; Wu P; Ehrenberg B; Chen JY
Biomaterials; 2014 Nov; 35(34):9372-81. PubMed ID: 25132603
[TBL] [Abstract][Full Text] [Related]
11. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments.
Garland MJ; Cassidy CM; Woolfson D; Donnelly RF
Future Med Chem; 2009 Jul; 1(4):667-91. PubMed ID: 21426032
[TBL] [Abstract][Full Text] [Related]
12. Gold nanorod enhanced conjugated polymer/photosensitizer composite nanoparticles for simultaneous two-photon excitation fluorescence imaging and photodynamic therapy.
Li S; Shen X; Xu QH; Cao Y
Nanoscale; 2019 Nov; 11(41):19551-19560. PubMed ID: 31578535
[TBL] [Abstract][Full Text] [Related]
13. Two-photon photodynamic therapy of C6 cells by means of 5-aminolevulinic acid induced protoporphyrin IX.
Beck TJ; Burkanas M; Bagdonas S; Krivickiene Z; Beyer W; Sroka R; Baumgartner R; Rotomskis R
J Photochem Photobiol B; 2007 Jun; 87(3):174-82. PubMed ID: 17513121
[TBL] [Abstract][Full Text] [Related]
14. Role of mitochondria in cell death induced by Photofrin-PDT and ursodeoxycholic acid by means of SLIM.
Kinzler I; Haseroth E; Hauser C; Rück A
Photochem Photobiol Sci; 2007 Dec; 6(12):1332-40. PubMed ID: 18046490
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy: an update.
Dima VF; Vasiliu V; Dima SV
Roum Arch Microbiol Immunol; 1998; 57(3-4):207-30. PubMed ID: 11845434
[TBL] [Abstract][Full Text] [Related]
16. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.
You Y; Gibson SL; Hilf R; Davies SR; Oseroff AR; Roy I; Ohulchanskyy TY; Bergey EJ; Detty MR
J Med Chem; 2003 Aug; 46(17):3734-47. PubMed ID: 12904078
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of one- and two-photon activated photodynamic therapy with pyropheophorbide-a methyl ester in human cervical, lung and ovarian cancer cells.
Luo T; Wilson BC; Lu QB
J Photochem Photobiol B; 2014 Mar; 132():102-10. PubMed ID: 24607610
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.
Nowak-Sliwinska P; Karocki A; Elas M; Pawlak A; Stochel G; Urbanska K
Biochem Biophys Res Commun; 2006 Oct; 349(2):549-55. PubMed ID: 16945338
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
Domagala A; Stachura J; Gabrysiak M; Muchowicz A; Zagozdzon R; Golab J; Firczuk M
BMC Cancer; 2018 Feb; 18(1):210. PubMed ID: 29463237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
